Updates in Medical Oncology from SIOG meeting
Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...
28 Oct 2020
Treating ALL patients during the COVID-19 pandemic
Prof David Marks - University hospital Bristol NHS Foundation Trust, Bristol, UK
15 Oct 2020
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
12 Oct 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
22 Sep 2020
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
7 Sep 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Aug 2020
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected st...
Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
30 Jun 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients wit...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
1 May 2020
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated m...
Prof Alain Algazi -University of California San Francisco, San Francisco, USA
30 Apr 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
27 Jan 2020
The treatment landscape of occular melanoma
Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada
21 Oct 2019
